Abstract
Purpose
There is paucity of data regarding T-cells in paediatric AML patients. The aim of this prospective study was to evaluate trend of T-cell subset during disease course of paediatric AML patients and to see its correlation with patient characteristics and survival outcome.
Methods
T-cell subsets (CD3, CD4 and CD8) were evaluated by flow-cytometry at diagnosis, post-induction, post-treatment completion, at 3 months and 6 months post-treatment completion, and relapse in 29 pediatric AML patients. Trend of T-cells was plotted between group A (those in continuous remission) and group B (those who relapsed) patients.
Results
Patients with high WBC count had significantly higher number of CD3, CD4 and CD8 cell. Baseline Tcell subsets did not affect CR, EFS and OS; however, higher than median CD4 count predicted improved DFS [58% vs 25%; HR = 0.306 (0.10–0.93); P = 0.037]. On serial follow-up from post-induction till 3 months after completion of therapy, there was no difference in the absolute values of T cell subsets between group A and B patients.
Conclusion
Our study demonstrated T cell subsets are increased in AML subjects with high WBC count. CD4 cells have a positive impact on DFS. Serial follow-up has no impact on T cell subsets. Further studies in larger patient cohorts are needed to evaluate if CD4 population may serve as an immune biomarker for AML.
References
Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6(4):295–307
Porter DL (2011) Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies. Hematology Am Soc Hematol Educ Program 2011:292–298
Panoskaltsis N, Reid CDL, Knight SC (2003) Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia. Leukemia 17(4):716–730
Vogt V, Schick J, Ansprenger C, Braeu M, Kroell T, Kraemer D, Köhne C-H, Hausmann A, Buhmann R, Tischer J, Schmetzer H (2014) Profiles of activation, differentiation–markers, or β-integrins on T cells contribute to predict T cells’ antileukemic responses after stimulation with leukemia-derived dendritic cells. J Immunother 37:331–347
Schatorjé EJ, Gemen EF, Driessen GJ, Leuvenink J, van Hout RW, de Vries E (2012 Apr) Paediatric reference values for the peripheral T cell compartment. Scand J Immunol 75(4):436–444
Ismail MM, Abdulateef NAB (2017) Bone marrow T-cell percentage: A novel prognostic indicator in acute myeloid leukemia. Int J Hematol 105:453–464
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bansal, A.K., Sharawat, S.K., Gupta, R. et al. Serial Evaluation of T cell Subsets in Paediatric Acute Myeloid Leukaemia- a Prospective Study. Indian J Hematol Blood Transfus 38, 153–157 (2022). https://doi.org/10.1007/s12288-021-01436-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-021-01436-7